Skip to main content
Log in

Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia

Die Nutzung frühe Veränderungen in Dichte und Volumens der Ohrspeicheldrüse als Prädicator für Modifikationen am Ende der Therapie und der Intensität akuter Xerostomie

  • Original article
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

Abstract

Purpose

To quantitatively assess the predictive power of early variations of parotid gland volume and density on final changes at the end of therapy and, possibly, on acute xerostomia during IMRT for head-neck cancer.

Materials and methods

Data of 92 parotids (46 patients) were available. Kinetics of the changes during treatment were described by the daily rate of density (rΔρ) and volume (rΔvol) variation based on weekly diagnostic kVCT images. Correlation between early and final changes was investigated as well as the correlation with prospective toxicity data (CTCAEv3.0) collected weekly during treatment for 24/46 patients.

Results

A higher rΔρ was observed during the first compared to last week of treatment (−0,50 vs −0,05HU, p-value = 0.0001). Based on early variations, a good estimation of the final changes may be obtained (Δρ: AUC = 0.82, p = 0.0001; Δvol: AUC = 0.77, p = 0.0001).

Both early rΔρ and rΔvol predict a higher “mean” acute xerostomia score (≥ median value, 1.57; p-value = 0.01). Median early density rate changes for patients with mean xerostomia score ≥ / < 1.57 were −0.98 vs −0.22 HU/day respectively (p = 0.05).

Conclusions

Early density and volume variations accurately predict final changes of parotid glands. A higher longitudinally assessed score of acute xerostomia is well predicted by higher rΔρ and rΔvol in the first two weeks of treatment: best cut-off values were −0.50 HU/day and −380 mm3/day for rΔρ and rΔvol respectively. Further studies are necessary to definitively assess the potential of early density/volume changes in identifying more sensitive patients at higher risk of experiencing xerostomia.

Zusammenfassung

Ziel

Ziel der Studie ist die Untersuchung der prädiktiven Aussagekraft von frühen Veränderungen in Volumen und Dichte der Ohrspeicheldrüse in Bezug auf die finale Verformung zum Ende der Therapie sowie das Risiko von Xerostomie während der intesitätsmodulierten Strahlentherapie (IMRT) bei Kopf und Hals Tumoren.

Materialien und Methoden

Die Studie umfasst 46 Patienten (92 Speicheldrüsen). Für 24 Patienten wurden prospektiv gesammelte Toxizitätsdaten (CTCAEv3.0) während der Therapie ausgewertet. Die Reaktion auf die Behandlung wurde beobachtet anhand der tägliche Veränderung der Dichte (rΔρ) sowie des Volumens (rΔvol) der Ohrspeicheldrüsen. Die Beziehung zwischen frühen und späten Veränderungen, sowie der Zusammenhang mit den wöchentlich dokumentieren Toxitätsdaten wurde für 24 der 46 Fälle untersucht.

Ergebnisse

Am Anfang der Therapie wurde ein höheres rΔρ beobachtet (−0,50 vs −0,05HU, p-Wert = 0,0001) als gegen Therapieende. Basierend auf frühen Veränderungen kann die finale Verformung der Speicheldrüsen gut abgeschätzt werden (Δρ: AUC = 0.82, p = 0.0001; Δvol: AUC = 0.77, p = 0.0001). Sowohl der frühe rΔρ- als auch der rΔvol-Wert sagen eine höheres „mittlere“ Auftreten von Xerostomie für den Durchschnitt der untersuchten Population vorher (1.57; p-Wert = 0.01, log. Regression). Die mittlere frühe Veränderung der Dichte für Patienten mit mittlerem Xerostomie-Wert ≥ / < 1.57 waren −0.98 bzw. −0.22 HU (p = 0.05, Mann–Whitney-Test).

Schlussfolgerung

Frühe Dichte- und Volumenvariationen können präzise letztendliche Änderungen der Ohrspeicheldrüse vorhersagen. Eine akuten Xerostomie kann gut durch größere rΔρ- und rΔvol-Werte in den ersten zwei Behandlungswochen vorhergesagt werden: die beste Cut-off-Werte für rΔρ und rΔvol waren jeweils −0.50 HU/ Tag und −380 mm3/day. Weitere Studien sind notwendig, um das ganze Potenzial der frühen Dichte/ Volumen Änderungen für die Identifizierung sensibler Patienten mit einemerhöhten Mundtrockenheitsrisiko zu beurteilen.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Tribius S, Sommer J, Prosch C et al (2013) Xerostomia after radiotherapy. Strahlenther Onkol 189:216–222

    Article  CAS  PubMed  Google Scholar 

  2. Deasy JO, Moiseenko V, Marks L et al (2010) Radiotherapy dose-volume effects on salivary gland function. Int J Radiat Oncol Biol Phys 76(Suppl 3):S58–S63

    Article  PubMed Central  PubMed  Google Scholar 

  3. Bjordal K, Kaasa S, Mastekaasa A (1994) Quality of life in patients treated for head and neck cancer: a follow up study 7 to 11 years after radiotherapy. Int J Radiat Oncol Biol Phys 28:847–856

    Article  CAS  PubMed  Google Scholar 

  4. Silvers AR, Som PM (1998) Salivary glands. Radiol Clin North Am 36:941–966

    Article  CAS  PubMed  Google Scholar 

  5. Robar JL, Day A, Clancey J et al (2007) Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:1121–1130

    Article  PubMed  Google Scholar 

  6. Fiorino C, Rizzo G, Scalco E et al (2012) Density variation of parotid glands during IMRT for head–neck cancer: correlation with treatment and anatomical parameters. Radiother Oncol 104:224–229

    Article  PubMed  Google Scholar 

  7. Fiorino C, Dell’Oca I, Pierelli A et al (2007) Simultaneous integrated boost (SIB) for nasopharynx cancer with helical tomotherapy. Strahlenther Onkol 9:497–505

    Article  Google Scholar 

  8. Faggiano E, Fiorino C, Scalco E et al (2011) An automatic contour propagation method to follow parotid gland deformation during head-and-neck cancer tomotherapy. Phys Med Biol 56:775–791

    Article  CAS  PubMed  Google Scholar 

  9. Gulliford SL, Foo K, Morgan RC et al (2010) Dose-volume constraints to reduce rectal side effects from prostate radiotherapy: evidence from MRC RT01 trial ISRCTN47772397. Int J Radiat Oncol Biol Phys 76:747–754

    Article  PubMed  Google Scholar 

  10. Vásquez Osorio EM, Hoogeman, Al-Mamgani A et al (2008) Local anatomic changes in parotid and submandibular glands during radiotherapy for oropharynx cancer and correlation with dose, studied in detail with nonrigid registration. Int J Radiat Oncol Biol Phys 70:875–882

    Article  PubMed  Google Scholar 

  11. Broggi S, Fiorino C, Dell’Oca I et al (2010) A two-variable linear model of parotid shrinkage during IMRT for head and neck cancer. Radiother Oncol 94:206–212

    Article  PubMed  Google Scholar 

  12. Fiorentino A, Caivano R, Metallo V et al (2012) Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol 85:1415–1419

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  13. Ricchetti F, Wu B, McNutt T et al (2011) Volumetric change of selected organs at risk during IMRT for oropharyngeal cancer. Int J Radiat Oncol Biol Phys 80:161–168

    Article  PubMed  Google Scholar 

  14. Robar JL, Day A, Clancey J et al (2007) Spatial and dosimetric variability of organs at risk in head-and-neck intensity-modulated radiotherapy. Int J Radiat Oncol Biol Phys 68:1121–1130

    Article  PubMed  Google Scholar 

  15. Wu Q, Chi Y, Chen PY et al (2009) Adaptive replanning strategies accounting for shrinkage in head and neck IMRT. Int J Radiat Oncol Biol Phys 75:924–932

    Article  PubMed  Google Scholar 

  16. Stock M, Dörr F, Stromberger C et al (2010) Investigations on parotid gland recovery after IMRT in head and neck tumor patients. Strahlenther Onkol 186:665–71

    Article  PubMed  Google Scholar 

  17. Fiorino C, Maggiulli E, Broggi S et al (2011) Introducing the Jacobian-volume-histogram of deforming organs: application to parotid shrinkage evaluation. Phys Med Biol 56:3301–3312

    Article  PubMed  Google Scholar 

  18. Izumi M, Eguchi K, Nakamura H et al (1997) Premature fat deposition in the salivary glands associated with Sjogren syndrome: MR and CT evidence. AJNR Am J Neuroradiol 18:951–958

    CAS  PubMed  Google Scholar 

  19. Teshima K, Murakami R, Yoshida R et al (2012) Histopathological changes in parotid and submandibular glands of patients treated with preoperative chemoradiation therapy for oral cancer. J Radiat Res 53:492–496

    Article  PubMed  Google Scholar 

  20. Skrzynski W, Zielinska-Dabrowska A, Wachomicz M et al (2010) Computed tomography as source of electron density information for radiationtreatment planning. Strahlenther Onkol 186:327–333

    Article  PubMed  Google Scholar 

  21. Mutic S, Palta JR, Butker EK et al (2003) Quality assurance for computed-tomography simulators and the computed-tomography-simulation process: report of the AAPM Radiation Therapy Committee Task Group No. 66. Med Phys 30:2762–2792

    Article  PubMed  Google Scholar 

  22. Bohuslavizki KH, Klutmann S, Bleckmann C et al (1999) Salivary gland protection by amifostine in high-dose radioiodine therapy of differentiated thyroid cancer. Strahlenther Onkol 175:57–61

    Article  CAS  PubMed  Google Scholar 

Download references

Compliance with ethical guidelines

Acknowledgments

The study was funded by an AIRC grant (IG10521). Thanks to Deli A.M., Longoni L., Todica A., Vai A., Knopf A. for the German translation and Bagg F for the English review.

Conflict of interest

M. L. Belli, E. Scalco, G. Sanguineti, C. Fiorino, S. Broggi, N. Dinapoli, F. Ricchetti, V. Valentini, G. Rizzo, and G. M. Cattaneo state that there are no conflict of interest.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Claudio Fiorino PhD.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Belli, M., Scalco, E., Sanguineti, G. et al. Early changes of parotid density and volume predict modifications at the end of therapy and intensity of acute xerostomia. Strahlenther Onkol 190, 1001–1007 (2014). https://doi.org/10.1007/s00066-014-0669-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-014-0669-2

Keywords

Schlüsselwörter

Navigation